Clorox Co (CLX) Holdings Cut by Sigma Planning Corp

Sigma Planning Corp trimmed its position in shares of Clorox Co (NYSE:CLX) by 6.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 18,153 shares of the company’s stock after selling 1,318 shares during the period. Sigma Planning Corp’s holdings in Clorox were worth $2,913,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CLX. Athena Capital Advisors LLC acquired a new position in Clorox during the 4th quarter valued at $25,000. Meeder Asset Management Inc. acquired a new position in shares of Clorox in the 4th quarter valued at $26,000. Capital Financial Planning LLC acquired a new position in shares of Clorox in the 4th quarter valued at $32,000. Paragon Capital Management LLC acquired a new position in shares of Clorox in the 1st quarter valued at $35,000. Finally, City Holding Co. raised its stake in shares of Clorox by 150.0% in the 4th quarter. City Holding Co. now owns 250 shares of the company’s stock valued at $39,000 after buying an additional 150 shares in the last quarter. 77.70% of the stock is owned by hedge funds and other institutional investors.

Clorox stock traded up $0.57 during trading hours on Wednesday, reaching $147.40. 1,249,730 shares of the company’s stock traded hands, compared to its average volume of 1,207,122. The company has a current ratio of 1.10, a quick ratio of 0.66 and a debt-to-equity ratio of 2.93. Clorox Co has a fifty-two week low of $119.86 and a fifty-two week high of $167.70. The company has a market cap of $19.06 billion, a PE ratio of 23.55, a PEG ratio of 4.35 and a beta of 0.31.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.03). The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. The business’s revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.37 earnings per share. Research analysts forecast that Clorox Co will post 6.29 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be given a $1.06 dividend. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.88%. This is an increase from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date is Tuesday, July 30th. Clorox’s dividend payout ratio (DPR) is currently 61.34%.

A number of equities analysts have recently issued reports on CLX shares. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $177.00 price objective for the company in a research note on Monday, March 11th. BMO Capital Markets set a $175.00 target price on shares of Clorox and gave the stock a “buy” rating in a report on Tuesday, February 5th. Wells Fargo & Co reaffirmed a “hold” rating and issued a $157.00 target price on shares of Clorox in a report on Thursday, February 21st. Credit Suisse Group assumed coverage on shares of Clorox in a report on Wednesday, March 6th. They issued an “outperform” rating and a $172.00 target price on the stock. Finally, Barclays reissued a “hold” rating and set a $142.00 price objective on shares of Clorox in a report on Wednesday, February 6th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. Clorox presently has a consensus rating of “Hold” and an average target price of $149.29.

In related news, SVP Andrew J. Mowery sold 5,340 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $156.44, for a total value of $835,389.60. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.40% of the company’s stock.

WARNING: This article was published by Sundance Herald and is the property of of Sundance Herald. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://sundanceherald.com/2019/05/29/clorox-co-clx-position-decreased-by-sigma-planning-corp.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: How to execute a trade ex-dividend strategy?

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply